Potassium Citrate
Pharmaceutical Materials 2025-03-02
| Property | Details |
|---|---|
| Name | Potassium Citrate |
| CAS No. | 866-84-2 |
| Molecular Formula | C₆H₅K₃O₇ |
| Molecular Weight | 306.395 g/mol |
| Appearance | White crystalline powder, odorless, with a cool, salty taste |
| Solubility | Freely soluble in water and glycerol, insoluble in ethanol |
| Hygroscopicity | Slightly hygroscopic |
| Boiling Point | 309.6°C at 760 mmHg |
| Density | 1.187 g/cm³ |
| Primary Uses | |
| – Food Industry | Buffering agent, chelating agent, stabilizer, antioxidant, emulsifier, flavoring agent |
| – Pharmaceutical Industry | Treatment and prevention of hypokalemia, alkalinization of urine, prevention and treatment of urinary stones |
| Safety Information | |
| – ADI | No special provisions (FAO/WHO, 1994) |
| – Common Side Effects | Gastrointestinal irritation (nausea, vomiting, abdominal pain, diarrhea) |
| – Severe Side Effects | Hyperkalemia (weakness, numbness, anxiety, confusion, difficulty breathing, arrhythmias) |
| Production Method | Neutralization of citric acid with potassium hydroxide or potassium bicarbonate |
| Regulatory Information | Approved for use in various foods in China without specific dosage limits |
Disclaimer: The above content is for reference and communication only among industry insiders, and does not guarantee its accuracy or completeness. According to relevant laws and regulations and the regulations of this website, units or individuals who purchase related items should obtain valid qualifications and qualification conditions.
